Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
肿瘤突变负荷作为复发或转移性头颈部鳞状细胞癌患者接受度伐利尤单抗和/或曲美利尤单抗治疗生存期的预测因子
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-2765
Wildsmith, Sophie; Li, Weimin; Wu, Song; Stewart, Ross; Morsli, Nassim; Raja, Rajiv; Zhang, Qu; Ye, Jiabu; He, Philip; Shetty, Jagdish; Yovine, Alejandro; Holoweckyj, Nicholas; Real, Katia; Walker, Jill; Wrona, Magdalena; de Los Reyes, Melissa; Barker, Craig; Whiteley, Jessica; Haddad, Robert; Licitra, Lisa; Ferris, Robert; Fayette, Jérôme; Zandberg, Dan P; Siu, Lillian L; Mesía, Ricard
